Home » Topics » Regulatory

Regulatory
RSS

New dosage strengths of Coumadin available

Feb. 18, 1997

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

IND filed for novel HIV treatment from Steroidogenesis Inhibitors

Feb. 13, 1997

FDA approves product for hemophilia

Feb. 13, 1997

MGI Pharma seeks FDA approval of new indication for Salagen Tablets

Feb. 12, 1997

Novartis launches once-daily hypertension Rx

Feb. 12, 1997

NexMed licenses alprostadil cream

Feb. 12, 1997

Tretinoin gel cleared for marketing by FDA

Feb. 11, 1997

Cypress awarded grant for research related to its PROSORBA Column

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...